CAS 1673560-66-1
:PD-1-IN-17
Description:
PD-1-IN-17, identified by its CAS number 1673560-66-1, is a small molecule inhibitor that targets the programmed cell death protein 1 (PD-1) pathway, which plays a crucial role in immune regulation and cancer immunotherapy. This compound is part of a class of immunotherapeutic agents designed to enhance the immune response against tumors by blocking the PD-1 receptor, thereby preventing its interaction with ligands PD-L1 and PD-L2. The characteristics of PD-1-IN-17 include its potential to modulate immune responses, making it a candidate for cancer treatment, particularly in tumors that exploit the PD-1 pathway for immune evasion. Additionally, it may exhibit specific pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME) profiles, which are critical for its efficacy and safety in clinical applications. As with many investigational compounds, ongoing research is essential to fully elucidate its biological activity, therapeutic potential, and any associated side effects.
Formula:C13H22N6O7
Synonyms:- AUPM170
- 2-[[4-Amino-1-[5-(1-amino-2-hydroxypropyl)-1,3,4-oxadiazol-2-yl]-4-oxobutyl]carbamoylamino]-3-hydroxypropanoic acid
- L-Serine, N-[[[(1S)-4-amino-1-[5-[(1S,2R)-1-amino-2-hydroxypropyl]-1,3,4-oxadiazol-2-yl]-4-oxobutyl]amino]carbonyl]-
- PD1IN17,PD 1 IN 17
- PD-1-IN-17
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
PD-1-IN-17
CAS:<p>PD-1-IN-17 is an inhibitor of programmed cell death-1 (PD-1). PD-1-IN-17 inhibits 92% splenocyte proliferation at 100 nM.</p>Formula:C13H22N6O7Purity:99.6%Color and Shape:SolidMolecular weight:374.35
